# U.S. Department of Health and Human Services (HHS)

Type: Company

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/us-department-of-health-and-human-services-hhs-company
Canonical HTML page: https://getbiobrief.com/entity/us-department-of-health-and-human-services-hhs-company

## Recent coverage (2 stories)

### Pharma's drug-price deals: $0 enforcement, $0 penalties
2026-09-04 23:36:29 · Sentiment: Negative · Impact: 6/10 · Sources: 4

Lower drug prices are being pursued through voluntary deals rather than enforceable regulation, a September 2026 report finds. For biopharma, the result is reputational pressure without legal clarity, and 'victories' that have yet to materialize.
Full story: https://getbiobrief.com/story/pharma-voluntary-drug-pricing-deals-zero-enforcement

### CMND-100: Clearmind's Non-Hallucinogenic Neuroplastogen Targets 5-HT1A for AUD
2026-07-11 00:45:15 · Sentiment: Neutral · Impact: 6/10 · Sources: 4

Clearmind Medicine submitted a response to an HHS RFI highlighting its clinical-stage candidate CMND-100, an MEAI-based neuroplastogen for Alcohol Use Disorder. The drug engages 5-HT1A pathways without hallucinogenic effects, offering a novel mechanism for addiction treatment.
Full story: https://getbiobrief.com/story/clearmind-cmnd100-neuroplastogen-rfi

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.